We report the isolation of a virus from a baboon imported from Kenya and the analysis of the nucleotide sequence of the env gene. Comparison of the complete nucleotide sequence of the env gene of different HTLV-1 strains and the baboon T-cell leukemia virus (designated BTLV) indicated similarities ranging from 92.5 to 97.4%. In contrast, only 89.1% similarity was observed between the BTLV env sequence and that of simian T-cell leukemia virus (PtM3). The sequences corresponding to the glycosylation sites, endoproteolytic processing site, and major immunological determinants were strictly conserved between BTLV and HTLV-1. To characterize the expressed protein we used a vaccinia expression system, which indicated that a protein of 62 kDa is encoded by the envelope gene. The protein acquired mostly high mannose modifications and was localized predominantly in the endoplasmic reticulum. A fraction of the protein was expressed at the cell surface, where it could induce membrane fusion of target cells. The existence of HTLV-1-like viruses in baboons indicates the potential risk of transmission of such virus from these nonhuman primates to humans, thus highlighting the need for specific screening for such viruses during xenotransplantation. ᭧
INTRODUCTION
Kenya. The nucleotide sequence of the envelope gene and the properties of the protein encoded by the gene Human T-cell leukemia virus type 1 (HTLV-1) is a Chave been determined. The nucleotide sequences have type retrovirus associated with adult T cell leukemia/ been compared with available sequences and the relatlymphoma (ATL) (Poiesz et al., 1980) . ATL is characteredness between different HTLV and STLV isolates and ized by the malignant proliferation of CD4/ T lymphothe possible evolutionary features are discussed. cytes with symptoms including hypercalcemia, lymphoadenopathy, skin lesions, involvement of the liver or MATERIALS AND METHODS spleen, and immunodeficiency (Stewart et al., 1994) . In addition, HTLV-1 infection is implicated in a demyelinatCells, viruses, and expression plasmid ing disorder, tropical spastic paraparesis (Furukawa et HeLa T4 cells (Maddon et al., 1986) and vaccinia virus al., 1992) , and other conditions including alveolitis and vTF7-3 (Fuerst et al., 1986) that synthesizes the T7 RNA arthritis. Simian T-cell leukemia virus type 1 polymerase in infected cells were obtained through the shares many properties with HTLV-1 and is associated AIDS Research and Reference Reagent Program and with the development of lymphomas in gorillas and maused for the expression studies. The gene encoding the caques, and leukemia in African green monkeys (Homma envelope glycoprotein of baboon T-cell leukemia virus et al., 1984; Schatzl et al., 1992) . HTLV-1 and STLV-1 (BTLV) was cloned under the control of the T7 promoter share common molecular features as well as pathogenic in the expression vector pcDNA-1 Amp (Invitrogen). Antiproperties. The genomic organization of both viruses is bodies used in this study were 1621 antiserum obtained similar, consisting of LTR-gag-pol-env-tax/rex-LTR.
from the BTLV-infected baboon or a monoclonal antibody Sequence analyses demonstrate that the genomes exto HTLV-1 (0.5 Alpha supernatant) obtained through the hibit an overall similarity of 90-95% (Watanabe et al., AIDS Research and Reference Reagent Program (Mat-1986) . sushita et al., 1986) . Although data are available on the nucleotide sequences of envelope genes from several HTLV and STLV Cloning of the BTLV envelope gene from genomic isolates, not much information is available on the proper-DNA ties of the proteins from viruses isolated from nonhuman primates. In this report, we describe the isolation of a Using primers (STLV-env1 5 CCGGATCCCAAAGAAnovel virus from a baboon (Papio anubis) imported from AAAGACCACC 3 and STLV-env2 5 GGTTAACTATTG-GCAGGGGAGGCTG 3) which are conserved for both HTLV-1 and STLV-1, PCR amplification was carried out
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using 2 units of Vent polymerase (New England Biolabs) left untreated. Both fractions were incubated at 37Њ for 15 hr and analyzed by SDS-PAGE. For tunicamycin treatwith 0.1 mg of the genomic DNA from a cell line developed from the infected baboon and each of the primers ment, transfected cells were treated with 5 mg/ml tunicamycin (Boehringer Mannheim) in DMEM for 30 min at 1 mM in a 100-ml volume containing 10 ml of 101 Vent buffer and 200 mM each dNTP. The amplification was prior to and during labeling. carried out for 20 cycles, denaturing at 95Њ (20 sec), annealing at 55Њ (20 sec), extension at 72Њ (60 sec), and Indirect immunofluorescence final incubation at 72Њ for 5 min. After precipitation and Cells were seeded onto coverglasses and infectionremoval of excess primers, the fragment was purified transfection was performed as described above. At 6 hr and cloned into the eukaryotic expression vector pcDNAposttransfection, the expression and cellular localization 1 Amp (Invitrogen).
of proteins were analyzed after fixing the transfected cells for 10 min with paraformaldehyde (3.6%) and per-DNA sequencing meabilizing for 5 min with 1.0% NP-40. Cells were then Both strands of the envelope gene were sequenced treated with primary antibodies specific to the envelope following the method recommended by United States protein followed by secondary mouse anti-human antiBiochemical, using Sequenase Version 2.0 T7 DNA polybodies conjugated with FITC. The coverslips containing merase. Briefly, 5 mg of alkali-denatured DNA was used the cells were extensively washed with PBS, mounted on for annealing with the primers at 65Њ for 2 min and the glass slides, and viewed in a fluorescence microscope. mix was allowed to cool slowly to 35Њ. To the annealed
The nucleotide sequence reported in this paper has template-primer complex (10 ml), 0.1 M DTT (1.0 ml), been submitted to GenBank under Accession No. diluted labeling mix (2.0 ml), 5 mCi of [a-35 S-dATP (0.5 ml)
U56855. and diluted Sequenase Version 2.0 (2.0 ml) were added and incubated for 3 min at room temperature. Meanwhile, RESULTS 2.5-ml aliquots of termination mix (ddGTP, ddATP, ddTTP, BTLV-infected baboon serum has strong reactivity to and ddCTP) were transferred to individual tubes and pre-HTLV-1 proteins warmed at 37Њ for 1 min. When labeling was complete, aliquots of 3.5 ml each were transferred to tubes conAs part of a collaborative project between the Yerkes taining corresponding termination mixes and incubated Regional Primate Research Center and the Institute of further for 5 min at 37Њ. The reaction was stopped and the Primate Research in Nairobi, Kenya, feral and captive samples were heated at 80Њ, loaded onto an acrylamidenonhuman primates in Kenya were screened for antibody urea gel, and visualized by autoradiography.
reactivity to HIV-1 and HIV-2. Several animal species tested positive for antibodies to HIV-2 using a commerTransfection, radioimmunoprecipitation, and protein cially available ELISA kit (Genetic Systems HIV-2 EIA): analysis Syke's monkeys, red tail monkeys, African green monkeys, and baboons, including a captive baboon with a Transfection and protein analyses were done as described previously (Vincent et al., 1993) . Briefly, cells (5 code designation of 1621. Baboon 1621 was further evaluated following importation to the Yerkes Center. 1 10 5 ) were seeded onto 35-mm dishes 1 day prior to transfection. The cells were infected with vaccinia virus Baboon 1621 was confirmed to be seropositive to HIV-2 (SIV) as well as HTLV-1 by Western blot (Fig. 1 ) and vTF7-3 (10 m.o.i.) which expresses the T7 RNA polymerase, and DNA (5 mg) and Lipofectin (10 mg) mix were commercially available ELISA. The reactivity of the baboon serum to HTLV proteins was evaluated by using added to the cells. At 15 hr posttransfection, the cells were starved in medium lacking methionine/cysteine and HTLV-1-infected cell lysate as the antigen source and then probing the blot strips with sera from an STLV-1-then labeled with 35 S labeling mix containing methionine and cysteine (Amersham) for 30 min. At the end of the positive sooty mangabey and from the baboon 1621. Sera from the STLV-1-positive sooty mangabey reacted with labeling period, label was removed and DMEM containing excess cold methionine and cysteine was added the envelope (gp46) and with the products of gag polyprotein (CA, p24; MA, p19; and NC, p15) ( Fig. 1 , lane 2). Sera and chased for different times as indicated. Cell lysates were prepared in RIPA buffer and proteins were immunofrom baboon 1621 exhibited a similar profile (lane 3). As expected, sera from an uninfected sooty mangabey did precipitated with specific antibodies. The immunoprecipitated proteins were extensively washed and analyzed not react with any of the HTLV-1 proteins. The proteins were also compared by radioactive labeling and immunoby SDS-PAGE and autoradiography. For experiments involving Endo H treatment, the immunoprecipitated proprecipitation to proteins from a cell line developed from baboon 1621 (described below). The sera from baboon teins were divided into two equal (100-ml) aliquots. To one aliquot 5 U Endo H (New England Biolabs) in sodium 1621 failed to precipitate any proteins of normal PBMC, whereas proteins corresponding in mobility to those phosphate buffer (pH 5.6) was added and the other was env gene was amplified using PCR primers as described under Materials and Methods.
Nucleotide sequence of envelope gene of BTLV
The nucleotide sequence of the BTLV env gene and the comparison with other HTLV-1 and STLV-1 isolates is shown in Fig. 2 . Of 1464 nucleotides, 1426 nt were found to be identical between HTLV-1 (EL strain) (Paine et al., 1991) and the BTLV isolate, i.e., 97.4% identity at the nucleotide level. Comparison of the complete nucleotide sequence of BTLV with different HTLV isolates revealed that the baboon virus env gene showed striking similarities ranging from 92.5 to 97.4%. In contrast, we found only 89.1% identity (1305 nt identical of 1464 nt) between the baboon virus env gene and that of STLV-1 (PtM3) (Watanabe et al., 1985) . When compared to the STLV-1 sequence, changes were clustered at the 5 end of the gene and, to a lesser extent, dispersed throughout the rest of the gene. Most base substitutions, however, were at the second (7.5%) or third (74.0%) position. STLV-1 strains isolated from Asia (86.4 to 90.2%).
As observed for HTLV and STLV isolates, the BTLV shown in the Western blot (Fig. 1) were precipitated from envelope protein was composed of 488 amino acids. the cell line developed from baboon 1621 (not shown).
Comparison of the amino acid sequence of the Env proThese results indicated the infection of the baboon 1621 tein of BTLV with that of HTLV-1 (strain MT2) (Gray et al., by a virus related to HTLV-1. 1990 ) revealed that 483 of 488 amino acids were identical with an overall similarity of 99.0%. Furthermore, 2 of the Development of a cell line and amplification of the 5 substitutions were conservative. The similarity of the envelope-coding region from genomic DNA BTLV Env protein with that of other HTLV-1 isolates ranged from 95 to 98%. On the other hand, the amino In order to isolate a virus from baboon 1621, PHA/IL-2-stimulated PBMC were cocultured with a number of acid similarity between the BTLV and the STLV-1 (PtM3) Env proteins was only 93.6%, indicating a greater divercell types (normal baboon PBMC, CEMss, CEM1174, Molt4 Clone 8, U937, and HuT78). All cocultures were gence. Of the 31 amino acid substitutions between the BTLV and the STLV-1 Env proteins, most of the substitufound to be negative for the presence of reverse transcriptase (RT) activity except for the CEMss coculture, tions were clustered in the signal peptide and gp46, with 4 changes in gp21. which showed minimal amounts of RT activity in the supernatant. This culture supernatant was tested for reactivity in an HTLV-I and -II antigen capture assay. Using
Expression of the BTLV envelope glycoprotein limiting dilution, cell lines were cloned from this coculture. Twenty-eight separate colonies which grew in the In order to characterize the protein encoded by the BTLV envelope gene, we performed transient transfec-0.1 cell/well dilution were expanded and tested for the presence of HTLV-I and -II antigen. Three clones were tion and immunoprecipitation using the vaccinia T7 expression system. A monoclonal antibody for HTLV-1, hupositive (4, 14, and 18), with the most strongly positive culture being No. 4 (termed 1621 clone 4). Genomic DNA man antiserum to HTLV-1, and sera from baboon 1621 all specifically immunoprecipitated a glycoprotein with was prepared from the 1621 clone 4 cell line and the lowed by SDS-PAGE. As shown in Fig. 3B , proteins synthesized during the 30-min pulse and subsequently digested with Endo H had a molecular weight of approximately 44 kDa. Even after chases up to 5 hr, the precursor protein did not exhibit forms which were resistant to Endo H. This result indicates that the BTLV envelope glycoprotein predominantly acquires high mannose modifications, occurring in the endoplasmic reticulum. In addition, we consistently found that the size of the unglycosylated proteins made during tunicamycin treat- relatively stable with a half-life of nearly 9 hr (data not After the 30-min pulse, the label was removed and medium containing shown). out the cell (Fig. 4A) . In addition, a low level of expression was observed at the cell surface by staining of unpermeabila molecular weight of approximately 62 kDa (data not ized cells (Fig. 4B ). Control cells similarly processed were shown).
negative for envelope-specific staining both within the cell The core molecular mass and nature of the modifica- (Fig. 4C ) and on the cell surface (Fig. 4D) . tion on the protein were analyzed using tunicamycin treatment of the transfected cells and endoglycosidase Induction of syncytia by the BTLV envelope protein H treatment of the immunoprecipitated proteins. The transfected cells were treated with tunicamycin for 30 HTLV induces syncytium formation upon infection of susceptible cells. In an attempt to determine if BTLV min prior to 35 S labeling and analyzed by immunoprecipitation (Fig. 3A) . In the absence of tunicamycin, the enveexhibited similar fusion properties, we analyzed the syncytia-forming potential of the BTLV Env protein using a lope precursor was found as a polyprotein of 62 kDa. A series of bands of faster electrophoretic mobility was coculture method. When HeLa T4 cells expressing BTLV Env were cocultured with XC cells, an RSV-transformed also observed, which may represent incompletely glycosylated forms of the protein. When glycosylation was rat cell line which is susceptible to cell fusion by HTLV-1, generation of syncytia containing 15-20 nuclei was inhibited, a protein band of approximately 46 kDa was observed representing the unglycosylated form of the observed (Fig. 5A) . The ability of the BTLV envelope protein to induce syncytia formation indicated that the proprecursor glycoprotein. A small fraction of the glycosylated protein was also observed during the tunicamycin tein was proteolytically processed and appropriately expressed at the cell surface for subsequent interaction treatment, possibly due to the limited time of exposure to the drug prior to labeling.
with its receptors. For comparison, we also cocultured XC cells and the cell line developed from baboon 1621 The nature of the modification of the protein was analyzed by labeling for 30 min and chasing in the presence from which BTLV was isolated. This coculture also resulted in the induction of syncytia with XC cells (Fig. 5B) , of unlabeled amino acids, and then digesting the immunoprecipitated proteins using endoglycosidase H folsuggesting that expression of viral proteins is main-
Comparison of env coding sequences of BTLV, HTLV-1, and STLV-1. Genomic DNA was prepared from the 1621 clone 4 cell line and used as template for PCR amplification of the Env coding region. The env gene of BTLV was sequenced using Sequenase version 2 (United States Biochemicals) and the nucleotide sequences were compared with the available sequences of HTLV strains (RH/K30, MT2, and EL) and STLV isolates (PtM3 and PPA) using the GCG program. Note that only 522 nucleotides of STLV-1 from PPA were available for comparison (Koralnik et al., 1994) . The deduced amino acid sequence of BTLV is presented at the bottom (BTLV AA). The Accession Nos. used in the comparison are RH/ K30 (L03561), MT2 (M37747), EL (M67514), PtM3 (M11373), and PPA (U03160). LTR suggested that there could be five different HTLV-1 genotypes from different geographic regions (Komurian cells alone (Fig. 5D ) or in combination with XC cells (Fig.  5C ) did not result in membrane fusion. These results et al., 1991; Ureta Vidal et al., 1994) . Koralnik et al. (1994) identified seven clades of STLV based on comparing 25 indicated that the vaccinia-expressed envelope protein possesses functional activity.
STLV-1 sequences from 12 nonhuman primate species. However, there are examples of STLV-1 sequences from a single host species that fit into genetically distinct DISCUSSION clades. We compared a segment between nucleotides Previous studies have indicated that African STLV-1 867 and 1388 of BTLV env, which has been used in most isolates exhibit a very close relationship among themof the published comparisons among different isolates selves and with HTLV-1 strain EL, isolated from an Afri- (Koralnik et al., 1994; Ibrahim et al., 1995) , with the correcan ATL patient (Paine et al., 1991; Song et al., 1994) .
sponding nucleotides of different STLV-1 and HTLV-1 The sequence of the envelope gene obtained from BTLV strains using the GCG program. Among HTLV-1 isolates is also similar to those of HTLV-1 EL. However, the amino the similarities ranged between 93.9 and 97.9%, the highacid sequence is more closely related to HTLV-1 strain est similarity being with H15 from Ivory Coast and lowest MT2, which was isolated from Japanese ATL patients. similarity to HZ17 from Zaire. Compared to the partial The HTLV strains EL and MT2 differ in 30 nucleotides env sequences of STLV clade S6 isolates from Africa, and 3 amino acids. Paine et al. (1991) compared different the BTLV sequence exhibited similarities ranging from HTLV-1 isolates and found fewer nucleotide and amino 94.6 to 96.1%. STLV-1 isolates from clade S7 (East Africa) acid differences in gp41 between isolates obtained from also exhibited 96.0% similarity to BTLV. An isolate from the same geographic region. STLV-1 strains from Africa a different species of baboon, PPA-5X28, showed the exhibited a closer genetic relatedness among themhighest similarity (97.5%) to BTLV. In contrast, STLV-1 selves and tend to segregate with HTLV-1 strain EL from isolates from India or Indonesia (clade S1) were found to equatorial Zaire. Sequence analyses of LTR, pol, and env show only 86.4 to 90.2% similarity to BTLV. A phylogenetic analysis based on the comparison of the 522-nucleotide regions and restriction fragment length polymorphism of segment of different HTLV-1 and STLV-1 isolates, using sites (McNearney et al., 1990) . Endoproteolytic processing has been shown to be an important determinant the Kimura distance matrix (Kimura, 1980) , showed that the BTLV sequence clustered with several of the isolates for biological activity of many viral glycoproteins including those of retroviruses. All retroviruses except visna from Kenya and Tanzania. However, the complete env gene sequence of BTLV shows greatest similarity to that have a highly conserved cleavage site for a trypsin-like protease (Arg-X-Lys/Arg-Arg) just prior to the beginning of HTLV-1 EL, which was isolated from Zaire. Since multiple amino acid substitutions have been observed in the of the transmembrane subunit (McCune et al., 1986) , and this site is recognized by a cellular protease resulting in amino-terminal region of the envelope gene of STLV-1 (Song et al., 1994) , comparison of such complete nucleothe generation of the surface and transmembrane components (Barr, 1991; Hallenberger et al., 1992) . The BTLV tide and amino acid sequences will be required to determine the precise relationship of BTLV to other primate envelope glycoprotein (gp62) has the sequence Arg-SerArg-Arg at aa 308 to 312, which is the probable cleavage T-cell leukemia viruses.
site for processing of the precursor (gp62) into the extraSeveral studies of retroviruses including HIV-1 indicellular (gp46) and transmembrane (gp21) components. cated that sequence variation in the env gene may proIn our initial labeling and immunoprecipitation studies, foundly affect virus infectivity, cell tropism, and other biono significant amount of gp46 was detected. However, in logical properties (Li et al., 1987; Szurek et al., 1988;  subsequent labeling studies with [
35 S]cysteine, we have Fenyo et al., 1988) . The envelope glycoproteins of all detected gp46 within the cell and in the extracellular HTLV-1 and STLV-1 viruses contain five potential sites medium (data not shown). Also, the observation of mem-(N-X-S/T) for N-linked glycosylation, which are conserved brane fusion by BTLV Env supports the conclusion that among strains (Paine et al., 1991) . The BTLV sequence a fraction of the precursor was cleaved. also shows strict conservation of these glycosylation sites. In this respect, HTLV-1 and STLV-1 differ from HIVSince BTLV has the potential to be used for the development of an animal model for HTLV-1, we compared its 1 which exhibits variation among strains in glycosylation
